13F filing recap · Q3 2021

What did Olstein Capital Management buy in Q3 2021?

Reported stock-position changes between this filing and the previous one. US-listed stocks across every Olstein account, including accounts that belong to no fund below.

Stock value

$816.16M

Positions

108

Estimated turnover

16.3%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

HRLHormel Foods Corporation$2.54Mreported value+62.0K shares NLSUSDNautilus Inc$1.58Mreported value+170.0K shares

Increased positions

DISCKDiscovery, Inc.$18.35Mreported value+94.6K shares+14.3%IVZInvesco Ltd.$16.26Mreported value+47.4K shares+7.6%ZBHZimmer Biomet Holdings, Inc.$14.64Mreported value+33.0K shares+49.3%DINDine Brands Global, Inc.$13.32Mreported value+30.5K shares

Reduced positions

CVSCVS Health Corp$15.02Mreported value-3.0K shares-1.7%WCCWesco International, Inc.$14.88Mreported value-27.0K shares-17.3%STSensata Technologies Holding Plc$13.65Mreported value-2.9K shares-1.1%CFGCitizens Financial Group Inc/ri$12.45Mreported value-2.0K shares

Exited positions

ACNAccenture Plc$4.27Mprior reported value-14.5K shares-100.0%